Kasr Alainy medical school
Cairo, 12111, Egypt
NCT Number: NCT06797557
Three or two measurements (according to GA) using 2D and 3D ultrasound examinations will be done at initial assessment of the participants then after 1 to 2 weeks and at the end of the 12th week of gestation
Looking for future studies?
Notify Me19 year–39 year
Female
Observational
Cairo, 12111, Egypt
First ultrasound scans: between 6 and 11 weeks of gestation that included the following:
Follow up scans was done one to two weeks later according the patient condition then at the end of 1st trimester where the previously mentioned parameters were measured.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
3D ultrasound rotational VOCAL method was used. YSV measurement (axial, sagittal and coronal). The sagittal plane was chosen as the reference plane and 'scanned' to obtain the longest axis of the yolk sac. Then a magnification of image was used and the yolk sac moved to the center of the plane. The VOCAL switch was then activated using a 30° rotation angle and the manual setting. Calipers were positioned on the superior and inferior extremities of the structure and after obtaining six sequential planes, the equipment automatically displayed the yolk sac as a 3D image with its volume in cm3
Time frame: 12 weeks of gestational age
continuation of pregnancy beyond 12 weeks of gestation
Cairo University
Other
Biochemical, 2D and 3D Ultrasonographic Predictors of Pregnancy Outcome in Women With Threatened Abortion: A Prospective Cohort Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07608133
Abortion, Threatened, Early Pregnancy Bleeding
Islamabad, Punjab Province, Pakistan
View Trial DetailsNCT02633878
Abortion, Threatened, Female Urogenital Diseases and Pregnancy Complications
Hefei, Anhui, China
View Trial DetailsNCT06011057
Abortion, Threatened, Female Urogenital Diseases and Pregnancy Complications
Cairo, Egypt
View Trial DetailsNCT03309735
Abortion, Spontaneous, Abortion, Threatened
Ufa, Bashkortostan Republic, Russia
View Trial Details